Your browser doesn't support javascript.
loading
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
Schuldner, Maximiliane; Dörsam, Bastian; Shatnyeva, Olga; Reiners, Katrin S; Kubarenko, Andriy; Hansen, Hinrich P; Finkernagel, Florian; Roth, Katrin; Theurich, Sebastian; Nist, Andrea; Stiewe, Thorsten; Paschen, Annette; Knittel, Gero; Reinhardt, Hans C; Müller, Rolf; Hallek, Michael; von Strandmann, Elke Pogge.
Afiliación
  • Schuldner M; Experimental Tumor Research, Center for Tumor Biology and Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University, Marburg, Germany.
  • Dörsam B; Innate Immunity Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Shatnyeva O; Experimental Tumor Research, Center for Tumor Biology and Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University, Marburg, Germany.
  • Reiners KS; Innate Immunity Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Kubarenko A; Innate Immunity Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Hansen HP; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Finkernagel F; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Roth K; Innate Immunity Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Theurich S; Institute of Molecular Biology and Tumor Research (IMT), Center for Tumor Biology and Immunology (ZTI), Philipps University, Marburg, Germany.
  • Nist A; Center for Tumor Biology and Immunology (ZTI), Core Facility Cellular Imaging, Philipps University, Marburg, Germany.
  • Stiewe T; Cancer and Immunometabolism Research Group, Department I of Internal Medicine, University Hospital of Cologne, Germany (current address: Department of Medicine III, University Hospital Munich, LMU, Germany).
  • Paschen A; Institute of Molecular Oncology and Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps University Marburg, Germany.
  • Knittel G; Institute of Molecular Oncology and Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps University Marburg, Germany.
  • Reinhardt HC; Department of Dermatology, University Hospital Essen, Essen and German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany.
  • Müller R; Clinic I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Hallek M; Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • von Strandmann EP; Center of Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Theranostics ; 9(21): 6047-6062, 2019.
Article en En | MEDLINE | ID: mdl-31534536
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Nucleares / Proteína p53 Supresora de Tumor / Chaperonas Moleculares / Exosomas / Melanoma Tipo de estudio: Screening_studies Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2019 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Nucleares / Proteína p53 Supresora de Tumor / Chaperonas Moleculares / Exosomas / Melanoma Tipo de estudio: Screening_studies Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2019 Tipo del documento: Article País de afiliación: Alemania